Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Canada Research Chairs

University of Toronto

$100,000.00

Bioelectrochemistry of proteins

EF 2023-24

Résumé
Dr. Kerman aims to develop a new generation of analytical methods and biosensors that would aid understanding the fundamental molecular interactions of "oxidative stress theory" in Alzheimer’s disease (AD). As the leading form of dementia, AD impacts Canada from two fronts: diminishing quality of life and over-burdening the health care system. To address the urgent need for effective AD treatment, the original and innovative research program will accelerate the study of antioxidant polyphenols as AD therapeutics. The proposed research program is focused on the study of polyphenol (gallic acid, ellagic acid, okadaic acid)-protein (tau, amyloid-beta and apolipoprotein E4) interactions in the presence of biometals (iron, copper and zinc). The four objectives of the program are the study of the interaction between polyphenols and biomarker proteins, measuring the antioxidant properties of polyphenols, the detection of lipid and DNA oxidation and the study of intracellular ROS formation. The chair aims to compare the rate of reactive oxygen species (ROS) production from human neuronal cells before and after biometal exposure using a wide variety of analytical tools including electrochemical and spectroscopic techniques. The novelty of the research program will be based on discovering whether some of the polyphenols might prevent biometal-induced neurotoxicity, reduce ROS production, and maintain the cellular redox potential under AD-like pathological oxidative stress conditions. The multidisciplinary research program will shed light on the possible therapeutic effects of antioxidant polyphenols and explore the role of biometals in AD. Furthermore, the bioelectrochemical platform will facilitate future studies with other small molecules for the treatment of AD. The expected significance of the work is expanding the therapeutic directions to promote development of new medications, thereby providing effective and safe treatments. The results of this research program will offer better prospects for AD individuals, benefit Canadian economy by alleviating AD-associated costs, and position Canada, especially Ontario, as a leader in biosensor research with training of the next generation of Canadian research talents.
Programme
Canada Research Chairs
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
CRC-2021-00068
Name nom
Kerman, Kagan
Department département
Physical and Environmental Sciences - University of Toronto
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2021
Award amount
100000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
10000
Area of application group en
The socioeconomic objective available
Area of application group fr
L'objectif socioéconomique disponible
Area of application en
The socioeconomic objective available
Area of application fr
L'objectif socioéconomique disponible
Research subject code
10000
Research subject group en
The field of research available
Research subject group fr
The field of research available
Research subject en
Le domaine de recherche disponible
Research subject fr
Le domaine de recherche disponible
Field of research list codes
RDF1040107
Field of research list names en
Separation science
Field of research list names fr
Science des séparations
Socioeconomic objective list codes
RDS10799
Socioeconomic objective list names en
Health, n.e.c.
Socioeconomic objective list names fr
Santé, n.c.a.
Application title
Bioelectrochemistry of proteins
Keyword
Bioelectrochemistry; Biosensor; Sensor; Chemical Neuroscience; Electroanalytical Chemistry; Alzheimer's disease; Neurodegenerative diseases; Protein misfolding
Application summary
Dr. Kerman aims to develop a new generation of analytical methods and biosensors that would aid understanding the fundamental molecular interactions of "oxidative stress theory" in Alzheimer’s disease (AD). As the leading form of dementia, AD impacts Canada from two fronts: diminishing quality of life and over-burdening the health care system. To address the urgent need for effective AD treatment, the original and innovative research program will accelerate the study of antioxidant polyphenols as AD therapeutics. The proposed research program is focused on the study of polyphenol (gallic acid, ellagic acid, okadaic acid)-protein (tau, amyloid-beta and apolipoprotein E4) interactions in the presence of biometals (iron, copper and zinc). The four objectives of the program are the study of the interaction between polyphenols and biomarker proteins, measuring the antioxidant properties of polyphenols, the detection of lipid and DNA oxidation and the study of intracellular ROS formation. The chair aims to compare the rate of reactive oxygen species (ROS) production from human neuronal cells before and after biometal exposure using a wide variety of analytical tools including electrochemical and spectroscopic techniques. The novelty of the research program will be based on discovering whether some of the polyphenols might prevent biometal-induced neurotoxicity, reduce ROS production, and maintain the cellular redox potential under AD-like pathological oxidative stress conditions. The multidisciplinary research program will shed light on the possible therapeutic effects of antioxidant polyphenols and explore the role of biometals in AD. Furthermore, the bioelectrochemical platform will facilitate future studies with other small molecules for the treatment of AD. The expected significance of the work is expanding the therapeutic directions to promote development of new medications, thereby providing effective and safe treatments. The results of this research program will offer better prospects for AD individuals, benefit Canadian economy by alleviating AD-associated costs, and position Canada, especially Ontario, as a leader in biosensor research with training of the next generation of Canadian research talents.